Clene Nanomedicine has submitted an application to the U.S. Food and Drug Administration (FDA) seeking accelerated approval of its experimental oral therapy CNM-Au8 for people with amyotrophic lateral ...

The ALS Association has launched a nationwide campaign to help people with amyotrophic lateral sclerosis (ALS) fight insurance denials that delay or prevent access to prescribed treatments, medical ...

Ever since I met my late husband, Jeff, who died from ALS in 2020, I had wanted to go. It was a meaningful place to him; in 1995, he served as part of the Bureau of Alcohol, Tobacco, Firearms and ...

People who smoke may have a greater chance of developing amyotrophic lateral sclerosis (ALS). For anyone already living with the condition, this habit can place extra strain on the lungs and make ...

Amyotrophic lateral sclerosis (ALS) damages the motor nerves that control voluntary movement. As the condition progresses, affected muscles, including those responsible for breathing, become weaker, ...

That’s according to a new study from Germany that found that quantifying levels of chitinases, a family of proteins linked to ...

A new AI model shows promise for predicting genetic ALS risk regardless of family history or known mutations. Capsule Networks can distinguish people with ALS from unaffected individuals, with a high ...

Electrical spinal stimulation can reduce toxic TDP-43 protein aggregates in preclinical ALS mouse models, a study reports.

Neurodegeneration—including ALS and frontotemporal dementia (FTD)—happens when nerve cells die faster than the body can protect them. Most current ALS medicines slow this loss a little, but they don’t ...

A novel treatment for amyotrophic lateral sclerosis (ALS) caused by mutations in a specific gene called CHCHD10 showed promise for slowing disease progression in a clinical trial that tested the ...